butenolide has been researched along with Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carta, F; Maresca, A; Scozzafava, A; Supuran, CT | 1 |
| Fujita, Y; Ito, M; Mizuguchi, Y; Nakagawa, K; Okano, T; Yamano, Y; Yoshida, M | 1 |
2 other study(ies) available for butenolide and Neoplasms
| Article | Year |
|---|---|
5- and 6-membered (thio)lactones are prodrug type carbonic anhydrase inhibitors.
Topics: Antineoplastic Agents; Carbonic Anhydrase Inhibitors; Chemistry, Pharmaceutical; Coumarins; Drug Design; Enzyme Inhibitors; Humans; Kinetics; Lactones; Models, Chemical; Neoplasms; Prodrugs; Protein Isoforms | 2012 |
Biological activities of retinoidal gamma-hydroxybutenolides in cancer cell apoptosis and differentiation.
Topics: 4-Butyrolactone; Apoptosis; Cell Differentiation; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Hydrogen; Molecular Structure; Neoplasms; Transcription, Genetic; Tretinoin | 2005 |